Cian Healthcare (BOM:542678) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542678 Cian Healthcare Ltd BOM:542678
49 GF Score
Price ₹9.55
GF Value ₹82.33
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Cian Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

BOM:542678
49GF Score
Cian Healthcare Ltd BOM:542678
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cian Healthcare (BOM:542678) Overvalued in 2026?

Based on GuruFocus' analysis, Cian Healthcare stock appears to be undervalued. The current stock price of ₹9.55 is trading 88.4% below its estimated GF Value™ of ₹82.33. GuruFocus considers Cian Healthcare to be Possible Value Trap.

Key valuation signals for BOM:542678:

  • FFO:
  • GF Value™: ₹82.33 vs. price of ₹9.55 (88.4% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cian Healthcare Business Description

Address Mundhwa Kharadi Road, Kirtane Baugh, Office No 301 Konark Icon 3rd Floor, Magarpatta Hadapsar, Mundhwa, Pune, MH, IND, 411036
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
49GF Score

Get the complete analysis for BOM:542678

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.55
Price
₹82.33
GF Value